Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARFILZOMIB Cause Multiple organ dysfunction syndrome? 123 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Multiple organ dysfunction syndrome have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.6% of all adverse event reports for CARFILZOMIB.

123
Reports of Multiple organ dysfunction syndrome with CARFILZOMIB
0.6%
of all CARFILZOMIB reports
106
Deaths
77
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From CARFILZOMIB?

Of the 123 reports, 106 (86.2%) resulted in death, 77 (62.6%) required hospitalization, and 45 (36.6%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

Yes, Multiple organ dysfunction syndrome is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.

What Other Side Effects Does CARFILZOMIB Cause?

Plasma cell myeloma (2,238) Off label use (2,120) Death (1,442) Thrombocytopenia (1,265) Fatigue (1,048) Pneumonia (1,016) Pyrexia (969) Anaemia (910) Dyspnoea (881) Neutropenia (874)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which CARFILZOMIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

CARFILZOMIB vs CARGLUMIC ACID CARFILZOMIB vs CARIPRAZINE CARFILZOMIB vs CARISOPRODOL CARFILZOMIB vs CARMUSTINE CARFILZOMIB vs CARTEOLOL

Related Pages

CARFILZOMIB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome CARFILZOMIB Demographics